Many factors must be considered when prescribing a particular treatmen
t regimen for patients with hypertensive and vascular disease. Among t
hem are desired reduction of blood pressure; effect on target-organ di
sease; control of risk factors for premature fatal and nonfatal cardio
vascular, cerebrovascular, and renovascular events; adverse reactions;
cost-effectiveness; and cost-benefit ratio. The newer classes of anti
hypertensive agents (ie, calcium antagonists and angiotensin-convertin
g enzyme inhibitors) in conjunction with nitric oxide donors and lipid
-lowering agents are an important addition to treatment regimens.